Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle

Dirk Daelemans; Jean‐Maurice Dumont; Brigitte Rosenwirth; De Clercq Erik; Christophe Pannecouque

doi:10.1016/j.antiviral.2009.10.009

Related publications

Article2008

Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent

Roger G. Ptak, Philippe Gallay, Dirk Jochmans, Andrew P. Halestrap, Urs T. Rüegg, Luke A. Pallansch, Michael Bobardt, Marie‐Pierre de Béthune, Johan Neyts, De Clercq Erik, Jean‐Maurice Dumont, Piétro Scalfaro, Kamel Besseghir, Roland M. Wenger, Brigitte Rosenwirth

Article2006

The cyclophilin inhibitor DEBIO-025 is a potent inhibitor of Hepatitis C virus replication in vitro

Lotte Coelmont, Jan Paeshuyse, Artur Kaul, Inge Vliegen, De Clercq Erik, Piétro Scalfaro, Brigitte Rosenwirth, R. Crabbé, JM Dumont, Ralf Bartenschlager, Johan Neyts

Article2004

Expression of HIV‐1 integrase in CEM cells inhibits HIV‐1 replication

Johan van Griensven, Xiaojing Zhan, Bénédicte Van Maele, Wim Pluymers, Martine Michiels, De Clercq Erik, Peter Cherepanov, Zeger Debyser

Article2006

The non‐immunosuppressive cyclosporin DEBIO‐025 is a potent inhibitor of hepatitis C virus replication in vitro†

Jan Paeshuyse, Artur Kaul, De Clercq Erik, Brigitte Rosenwirth, Jean‐Maurice Dumont, Piétro Scalfaro, Ralf Bartenschlager, Johan Neyts

Article2007

The Cyclophilin Inhibitor Debio-025 is a Potent Inhibitor of Hepatitis C Virus Replication in vitro With a Unique Resistance Profile

Lotte Coelmont, Jan Paeshuyse, Suzanne J. F. Kaptein, Inge Vliegen, Ajay Kaul, De Clercq Erik, Brigitte Rosenwirth, Piétro Scalfaro, R. Crabbé, Ralf Bartenschlager